CVRx Inc.
(CVRX)
undefined
undefined%
At close: undefined
12.83
0.12%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.
It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF.
The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally.
CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
CVRx Inc.
| Country | United States |
| IPO Date | Jun 30, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 200 |
| CEO | Kevin Hykes |
Contact Details
Address: 9201 West Broadway Avenue Minneapolis, Minnesota United States | |
| Website | https://www.cvrx.com |
Stock Details
| Ticker Symbol | CVRX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001235912 |
| CUSIP Number | 126638105 |
| ISIN Number | US1266381052 |
| Employer ID | 00-0000000 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kevin Hykes | President, Chief Executive Officer & Director |
| Jared Oasheim | Chief Financial Officer |
| Bonnie Handke M.B.A., R.N. | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics |
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer |
| Jennifer E. Englund | Senior Vice President of Global Clinical Affairs |
| Jonelle R. Burnham | Vice President & General Counsel |
| Paul Pignato | Vice President of Operations |
| Paul Verrastro | Chief Marketing & Strategy Officer |
| Robert Allen John | Chief Revenue Officer |
| Tonya A. Austin SPHR | Chief Human Resources Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 21, 2024 | 4 | Filing |
| Nov 07, 2024 | SC 13D/A | [Amend] Filing |
| Nov 04, 2024 | 8-K | Current Report |
| Nov 01, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 01, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | 8-K | Current Report |
| Oct 01, 2024 | 8-K | Current Report |
| Sep 05, 2024 | 4 | Filing |
| Sep 05, 2024 | 4 | Filing |
| Sep 05, 2024 | 3 | Filing |